About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
St3gal4tm1.1Bsi
targeted mutation 1.1, RIKEN Brain Science Institute
MGI:5695539
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
St3gal4tm1.1Bsi/St3gal4tm1.1Bsi B6J.B6N-St3gal4tm1.1Bsi MGI:5811794


Genotype
MGI:5811794
hm1
Allelic
Composition
St3gal4tm1.1Bsi/St3gal4tm1.1Bsi
Genetic
Background
B6J.B6N-St3gal4tm1.1Bsi
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
St3gal4tm1.1Bsi mutation (2 available); any St3gal4 mutation (26 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• following repeated amygdala-kindling stimulation (once a day for 18 days), mice show a significant reduction in the number of afterdischarge spikes, duration of the afterdischarge period, freezing times, and transition among stages of seizure severity relative to wild-type controls on days 15-18; differences are most obvious on day 18
• on day 18, only 17% of mice exhibit tonic-clonic seizures versus 100% of wild-type controls, indicating protection against temporal lobe epilepsy

behavior/neurological
• in delay fear conditioning tests, mice show enhanced freezing during the auditory tone test, with a 2.2-fold increase in mean duration of freezing (%) for the 30-s period between 90 and 120 s and a 1.9-fold increase in total freezing times (%) relative to wild-type controls
• however, foot shock sensitivity, sensory processing, and freezing behaviors during the initial conditioning or contextual tests are normal
• in the tail suspension test, mice show a 1.1-fold decrease in the mean duration of total immobility (%) relative to wild-type controls, indicating decreased suspension despair
• in the forced swim test, mice show a 1.5-fold increase in the mean duration of total immobility (%) relative to wild-type controls, indicating increased swimming despair
• in the open-field test, mice enter the center of the arena less often than wild-type controls and fail to show an increase in the frequency of entry from the first to second trial, indicating poor acclimation to the center area
• however, total distance travelled during the three trials of 5-min test periods is normal
• mice show enhanced freezing during delay auditory fear conditioning
• mice fail to show siesta-like sleep between 00:00 and 04:00 hours, unlike wild-type controls
• mice show a 3.6-fold decrease in the mean duration of the REM period (%) relative to wild-type controls
• however, no differences are observed in awake or non-REM sleep periods
• following repeated amygdala-kindling stimulation (once a day for 18 days), mice show a significant reduction in the number of afterdischarge spikes, duration of the afterdischarge period, freezing times, and transition among stages of seizure severity relative to wild-type controls on days 15-18; differences are most obvious on day 18
• on day 18, only 17% of mice exhibit tonic-clonic seizures versus 100% of wild-type controls, indicating protection against temporal lobe epilepsy

homeostasis/metabolism
• mice show a 2.2-fold reduction of brain Igf1 mRNA levels in the apical part of the cerebral cortex relative to wild-type controls
• mice show a 2.8-fold reduction of brain growth hormone (GH) mRNA levels in the apical part of the cerebral cortex relative to wild-type controls





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory